Literature DB >> 10363447

[Epidemiology, clinical study and pathology of vasospasm].

F Turjman1, S Mimon, H Yilmaz.   

Abstract

Symptomatic vasospasms or delayed cerebral ischemia associated with arteriographic evidence of arterial constriction is currently the most important cause of morbidity after acute subarachnoid hemorrhage. Symptomatic vasospasm usually develops between 4 and 12 days after subarachnoid hemorrhage. There is typically a gradual deterioration of the level of consciousness accompanied by focal neurological deficits. 30% of patients who survived aneurysmal SAH develop delayed cerebral ischemia secondary to vasospasm. Vasospasm produces cerebral ischemia and infarction by hemodynamic mechanisms. Vasospasm is an important independent predictor of poor outcome after aneurysmal SAH. Other conditions than aneurysmal subarachnoid hemorrhage such as trauma, tumors, unruptured aneurysms, meningitis and ruptured AVM may be associated with vasospasm.

Entities:  

Mesh:

Year:  1999        PMID: 10363447

Source DB:  PubMed          Journal:  J Neuroradiol        ISSN: 0150-9861            Impact factor:   3.447


  2 in total

1.  Relative changes in flow velocities in vasospasm after subarachnoid hemorrhage: a transcranial Doppler study.

Authors:  Neeraj S Naval; Carole E Thomas; Victor C Urrutia
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

2.  Conditioning Effect of Inhalational Anesthetics on Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage.

Authors:  Umeshkumar Athiraman; Rajat Dhar; Keshav Jayaraman; Menelaos Karanikolas; Daniel Helsten; Jane Yuan; Abhijit V Lele; Girija Prasad Rath; Rene Tempelhoff; Steven Roth; Gregory J Zipfel
Journal:  Neurosurgery       Date:  2021-01-13       Impact factor: 4.654

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.